Skip to content
Screener

Onto Innovation ONTO Business Segments — Operating Income

Similar metrics at other companies

Alumis Inc. logo
ALMSSingle Reportable — Operating Income
-$98.41M+3.1%
Immunome logo
IMNMSingle Reportable — Operating Income
-$59.33M-32.9%
Capricor Therapeutics logo
CAPRSingle Reportable — Operating Income
-$36.77M-47.2%
LQD
LQDASingle Reportable — Operating Income
$61.5M+274%
Edgewise Therapeutics, Inc. logo
EWTXSingle Reportable — Operating Income
-$54.12M-17.7%
Theravance Biopharma logo
TBPHSingle Reportable — Operating Income
-$9.48M+34.3%

Other financials

Income statement

See full
Revenue$343.1M+35.3%
Gross profit$183.3M+50.1%
Operating income$63.6M+97.1%
Net income$60.1M+75.8%
EPS (diluted)$1.21+75.4%

Balance sheet

See full
Cash & equivalents$1.3B+476%
Total debt$17.5M+15.3%
Total equity$1.9B-2.1%
Total assets$3.7B+72.8%

Cash flow

See full
Operating cash flow$61.5M+6.2%
CapEx$3.7M-73.4%
Free cash flow$57.9M+31.0%

Valuation

See full
Market cap$13.73B+212%
P/E84.6×+58.6×
P/S12.3×+8.0×

Profitability

See full
Gross margin50.4%-1.2pp
Operating margin12%-6.4pp
Net margin14.5%-1.8pp
FCF margin22.5%-0.5pp

Returns & leverage

See full
Return on equity8.3%-0.6pp
Debt / equity0×0.0×
Current ratio9.7×+0.1×

Where this comes from

Reported directly by Onto Innovation in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Onto Innovation’s 10-K, filed February 24, 2026.

Filed
Feb 24, 2026, 4:04 PM EST
Fiscal year
FY2025
Accession
0001193125-26-066937
Line itemYear Ended / January 3,2026Year Ended / December 28,2024Year Ended / December 30,2023
Merger and acquisitions related (4)19,6017,6532,607
Litigation (4)—2711,337
Amortization39,40949,43754,823
Operating income132,927187,103116,078
Interest income, net34,97133,48920,356
Other expense, net(4,996)(145)(3,852)
Provision for income taxes26,14318,77711,423
Net income$136,759$201,670$121,159

Item 16. Form 10-K Summary.

FAQ

What is Onto Innovation's business segments — operating income?
Onto Innovation (ONTO) reported business segments — operating income of $33.23M in Q4 2025.
How has Onto Innovation's business segments — operating income changed year-over-year?
Onto Innovation's business segments — operating income decreased by 29.0% year-over-year, from $46.78M to $33.23M.
What is the long-term trend for Onto Innovation's business segments — operating income?
Over 3 years (2022 to 2025), Onto Innovation's business segments — operating income has grown at a -17.5% compound annual growth rate (CAGR), from $236.71M to $132.93M.
What does business segments — operating income mean?
Measures the profit or loss generated from core business operations after deducting operating expenses. It is a key indicator of the company's ability to generate profit from its primary activities before interest and taxes.

Ask your AI about Onto Innovation's business segments — operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude